$6.07
2.10%
Nasdaq, Sep 29, 11:23 am EDT. Market open.
ISIN
KYG7487R1002
Symbol
RGC

Regencell Bioscience Holding Stock price

$6.20
+0.70 12.73% 1M
-17.13 73.42% 6M
-14.80 70.48% YTD
-10.19 62.17% 1Y
+5.83 1,553.33% 3Y
+5.75 1,271.38% 5Y
+5.92 2,143.94% 10Y
+5.92 2,143.94% 20Y
Nasdaq, Closing price Mon, Sep 28 2026
+0.03 0.49%
ISIN
KYG7487R1002
Symbol
RGC
Industry

Is Regencell Bioscience Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$3.1b
Enterprise Value
$3.1b
Net debt
positive
Cash
$2.4m
Shares outstanding
494.5m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
2,518.0
Financial Health
Equity Ratio
84.4%
Return on Equity
-73.7%
ROCE
-532.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | -
EBITDA
-
EBIT
$-7.1m
Net Income
$-7.1m
Free Cash Flow
$-2.6m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-
EBIT
-62.0%
Net Income
-72.4%
Free Cash Flow
-
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$0.0
FCF per Share
$0.0
Short interest
1.5%
Employees
10
Rev per Employee
$0.0

Financial data from Regencell Bioscience Holding

Dec '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 6.28 6.28
90% 90%
-
- Research and Development Expense 0.86 0.86
21% 21%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -7.13 -7.13
62% 62%
-
Net Profit -7.05 -7.05
72% 72%
-

In millions USD.

Don't miss a Thing! We will send you all news about Regencell Bioscience Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Regencell Bioscience Holding Stock News

Neutral
Accesswire
●
3 months ago
VANCOUVER, BC / ACCESS Newswire / June 18, 2026 / Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) (the "Company" or "Relevant Gold") is pleased to announce the voting results from its Annual and Special General Meeting of Shareholders (the "Meeting") held today in Vancouver, British Columbia. Shareholders approved all matters brought before the Meeting, including: Setting the number of directors at...
Neutral
Accesswire
●
3 months ago
Airborne VTEM and magnetics survey identifies 44+ EM anomalies, including 15 high-priority targets, several coincident with known gold-bearing structures, surface geochemistry and 2024 drilling VANCOUVER, BC / ACCESS Newswire / June 18, 2026 / Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) (the "Company" or "Relevant Gold") is pleased to announce results from a 2,807 line-km Versatile Time Domain ...
Neutral
GlobeNewsWire
●
4 months ago
Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Regencell (RGC) To Contact Him Directly To Discuss Their Options
More Regencell Bioscience Holding News

Company Profile

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Head office Cayman Islands
Employees 10
Website www.regencellbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today